vs

Side-by-side financial comparison of Civeo Corp (CVEO) and Liquidia Corp (LQDA). Click either name above to swap in a different company.

Civeo Corp is the larger business by last-quarter revenue ($161.6M vs $92.0M, roughly 1.8× Liquidia Corp). Liquidia Corp runs the higher net margin — 15.8% vs -4.0%, a 19.8% gap on every dollar of revenue. On growth, Liquidia Corp posted the faster year-over-year revenue change (3054.6% vs 7.1%). Liquidia Corp produced more free cash flow last quarter ($42.2M vs $14.5M).

The Civeo Corporation is an American accommodation services multinational corporation. It is a spin-off of Oil States International. It is a public company listed on the New York Stock Exchange.

Liquidia Corp is a late-stage biopharmaceutical firm focused on developing and commercializing innovative inhaled therapies for respiratory and rare diseases. It uses its proprietary PRINT particle engineering tech to create optimized drug products, with core markets in North America covering pulmonary arterial hypertension and asthma indications.

CVEO vs LQDA — Head-to-Head

Bigger by revenue
CVEO
CVEO
1.8× larger
CVEO
$161.6M
$92.0M
LQDA
Growing faster (revenue YoY)
LQDA
LQDA
+3047.6% gap
LQDA
3054.6%
7.1%
CVEO
Higher net margin
LQDA
LQDA
19.8% more per $
LQDA
15.8%
-4.0%
CVEO
More free cash flow
LQDA
LQDA
$27.8M more FCF
LQDA
$42.2M
$14.5M
CVEO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CVEO
CVEO
LQDA
LQDA
Revenue
$161.6M
$92.0M
Net Profit
$-6.5M
$14.6M
Gross Margin
22.7%
Operating Margin
-0.1%
21.5%
Net Margin
-4.0%
15.8%
Revenue YoY
7.1%
3054.6%
Net Profit YoY
58.1%
137.9%
EPS (diluted)
$-0.58
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVEO
CVEO
LQDA
LQDA
Q4 25
$161.6M
$92.0M
Q3 25
$170.5M
$54.3M
Q2 25
$162.7M
Q1 25
$144.0M
Q4 24
$151.0M
Q3 24
$176.3M
Q2 24
$188.7M
Q1 24
$166.1M
Net Profit
CVEO
CVEO
LQDA
LQDA
Q4 25
$-6.5M
$14.6M
Q3 25
$-455.0K
$-3.5M
Q2 25
$-3.3M
Q1 25
$-9.8M
Q4 24
$-15.4M
Q3 24
$-5.1M
Q2 24
$8.2M
Q1 24
$-5.1M
Gross Margin
CVEO
CVEO
LQDA
LQDA
Q4 25
22.7%
Q3 25
25.7%
Q2 25
25.3%
Q1 25
20.4%
Q4 24
18.6%
Q3 24
21.4%
Q2 24
25.4%
Q1 24
21.5%
Operating Margin
CVEO
CVEO
LQDA
LQDA
Q4 25
-0.1%
21.5%
Q3 25
4.1%
3.3%
Q2 25
1.7%
Q1 25
-3.8%
Q4 24
-6.7%
Q3 24
0.0%
Q2 24
6.9%
Q1 24
-1.1%
Net Margin
CVEO
CVEO
LQDA
LQDA
Q4 25
-4.0%
15.8%
Q3 25
-0.3%
-6.5%
Q2 25
-2.0%
Q1 25
-6.8%
Q4 24
-10.2%
Q3 24
-2.9%
Q2 24
4.4%
Q1 24
-3.1%
EPS (diluted)
CVEO
CVEO
LQDA
LQDA
Q4 25
$-0.58
$0.18
Q3 25
$-0.04
$-0.04
Q2 25
$-0.25
Q1 25
$-0.72
Q4 24
$-1.04
Q3 24
$-0.36
Q2 24
$0.56
Q1 24
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVEO
CVEO
LQDA
LQDA
Cash + ST InvestmentsLiquidity on hand
$14.4M
$190.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$174.4M
$44.7M
Total Assets
$477.4M
$327.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVEO
CVEO
LQDA
LQDA
Q4 25
$14.4M
$190.7M
Q3 25
$12.0M
$157.5M
Q2 25
$14.6M
Q1 25
$28.4M
Q4 24
$5.2M
Q3 24
$17.9M
Q2 24
$7.4M
Q1 24
$16.8M
Total Debt
CVEO
CVEO
LQDA
LQDA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$43.3M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CVEO
CVEO
LQDA
LQDA
Q4 25
$174.4M
$44.7M
Q3 25
$182.5M
$22.1M
Q2 25
$209.4M
Q1 25
$220.7M
Q4 24
$236.4M
Q3 24
$282.2M
Q2 24
$297.4M
Q1 24
$297.4M
Total Assets
CVEO
CVEO
LQDA
LQDA
Q4 25
$477.4M
$327.9M
Q3 25
$491.1M
$276.0M
Q2 25
$508.8M
Q1 25
$423.8M
Q4 24
$405.1M
Q3 24
$477.6M
Q2 24
$483.2M
Q1 24
$513.1M
Debt / Equity
CVEO
CVEO
LQDA
LQDA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.18×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVEO
CVEO
LQDA
LQDA
Operating Cash FlowLast quarter
$19.3M
$44.2M
Free Cash FlowOCF − Capex
$14.5M
$42.2M
FCF MarginFCF / Revenue
8.9%
45.9%
Capex IntensityCapex / Revenue
3.0%
2.2%
Cash ConversionOCF / Net Profit
3.04×
TTM Free Cash FlowTrailing 4 quarters
$2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVEO
CVEO
LQDA
LQDA
Q4 25
$19.3M
$44.2M
Q3 25
$13.8M
$-9.8M
Q2 25
$-2.3M
Q1 25
$-8.4M
Q4 24
$9.5M
Q3 24
$35.7M
Q2 24
$32.4M
Q1 24
$6.0M
Free Cash Flow
CVEO
CVEO
LQDA
LQDA
Q4 25
$14.5M
$42.2M
Q3 25
$8.2M
$-10.7M
Q2 25
$-6.8M
Q1 25
$-13.7M
Q4 24
$1.8M
Q3 24
$28.2M
Q2 24
$27.0M
Q1 24
$372.0K
FCF Margin
CVEO
CVEO
LQDA
LQDA
Q4 25
8.9%
45.9%
Q3 25
4.8%
-19.7%
Q2 25
-4.2%
Q1 25
-9.5%
Q4 24
1.2%
Q3 24
16.0%
Q2 24
14.3%
Q1 24
0.2%
Capex Intensity
CVEO
CVEO
LQDA
LQDA
Q4 25
3.0%
2.2%
Q3 25
3.3%
1.7%
Q2 25
2.8%
Q1 25
3.7%
Q4 24
5.1%
Q3 24
4.2%
Q2 24
2.8%
Q1 24
3.4%
Cash Conversion
CVEO
CVEO
LQDA
LQDA
Q4 25
3.04×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
3.93×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons